DEA MATE

Live Courses

UCSF Addiction CME Conference - April 23-24, 2026 Only!

The UCSF Addiction CME Conference is back for its 6th year - being held again VIRTUALLY on April 23-24, 2026! The course is ideal for physicians, nurse practitioners, and physician associates, and aims to increase the core competency of medical teams in the inpatient and outpatient settings to improve care for patients who use drugs and alcohol. This conference will increase skills in diagnosis, assessment, and treatment of common substance use disorders through didactics taught by local addiction experts, as well as small group discussions to apply this knowledge to patient care.

Topics covered will include:

  • Keynote address from a person with lived experience of Substance Use Disorder (SUD)
  • SUD as a brain disease
  • Stigma around Opioid Use Disorder, including starting buprenorphine and methadone
  • Alcohol Use Disorder
  • Benzodiazepine Use Disorder and withdrawal management
  • Stimulant Use Disorder
  • Pregnancy and SUDs
  • Pain and SUDs
  • Hospital based care for patients with SUDs
  • Communication and documentation in caring for patients with SUDs

Please visit the 2026 UCSF Addiction course page to register and for additional information about accreditation types. 

 

On-demand Courses

Access Addiction Medicine Online Course

UCSF Addiction Medicine
Course# MED27052

The MATE (Medication Access and Training Expansion) Act requires new or renewing DEA licensees (prescribers of schedule II – V controlled substances) to complete 8 hours of training on the treatment and management of patients with substance use disorders. The deadline to do so is the licensee’s upcoming DEA registration date.   
 
The UCSF Office of CME and Divisions of Hospital and General Internal Medicine have created an 8 hour training which meets this requirement and provides CME credit for a nominal fee. Please use the link above and login to our online learning system (CMECalifornia) to attend “the UCSF 2023 Addiction Medicine Online Course.”

Study at your own pace with eight videos focused on substance use disorder as a brain disease, methadone, buprenorphine inductions, stimulants and drug-involved deaths, hospital-based care, street medicine, pregnancy and SUD, and adolescent addiction medicine.

This CME opportunity meets the SAMHSA Medication Access and Training Expansion (MATE) Act 8-hour training requirement for DEA licensing or renewal.

Objectives

Upon completion of this activity, the participant will be able to:

  1. Apply new knowledge to better recognize substance use (SU) disorders;
  2. Revise screening practices to align with evidence-based recommendations for SU;
  3. Apply evidence-based treatments of SU disorders;
  4. Apply strategies to improve clinical team collaboration and practice;
  5. Apply communication strategies for more effective team care of patients with SU.

Access Treatment of Pediatric PaiN Online Course

Multimodal Treatment of Pediatric Pain to Avoid Addiction and Opioid Use Disorder 
Course# MED27053

The MATE (Medication Access and Training Expansion) Act requires new or renewing DEA licensees (prescribers of Schedule II – V controlled substances) to complete eight (8) hours of training on the treatment and management of patients with substance use disorders. This eight-hour online course specific to pediatric practice was recorded from the 12th Annual Pediatric Pain Master Class and aims to address the lack of formal training in pediatric pain management.

Study at your own pace with eight videos focused on multimodal analgesia adjuvant analgesia; chronic pain in head, abdomen, muscles and joints; avoiding anxiety during needle procedures; opioid mitigation; substance use disorder; and cannabis and cannabinoids. Optional content in neuropathic pain and needle pain prevention is also available.

This CME opportunity meets the SAMHSA Medication Access and Training Expansion (MATE) Act 8-hour training requirement for DEA licensing or renewal.

Objectives

  1. Upon completion of this activity, the participant will be able to:
  2. Use an evidence-based approach to multimodal analgesia in children
  3. Explain the optimal approach to chronic pain in children
  4. Describe the essential five “bundled” components of needle pain management
  5. Develop strategies to identify youth and families at risk for opioid related adverse outcomes and approaches to reduce these risks
  6. Develop strategies to diagnose and treat pediatric/adolescent substance use disorder
  7. Describe components of successful chronic pain management without opioids and further testing/imaging  in pediatric patients with chronic pain
  8. Compare the effectiveness and harms of cannabinoids in treatment of pediatric pain